Pulsed Field Ablation: A Game-Changer for Atrial Fibrillation Treatment at Fairfield Medical Center

Fairfield Medical Center recently introduced a revolutionary pulsed field ablation (PFA) therapy for the treatment of atrial fibrillation (afib), a dangerous arrhythmia that affects over 59 million people worldwide. This condition can lead to serious health problems if left untreated, such as heart failure and stroke.

The Medtronic PulseSelect™ PFA System is the latest breakthrough technology used in atrial fibrillation ablations, providing excellent results with a lower risk of complications compared to traditional ablation therapies. Traditional ablation techniques use thermal effects to form scar tissue within the heart, which can damage surrounding tissue and structures. In contrast, PFA uses pulsed electric fields to efficiently target, isolate, and eliminate triggers of the arrhythmia without relying on extremely hot or cold temperatures.

Cardiologist Alexander Hattoum, MD, who performed the first PFA procedures at FMC, stated that this technology has revolutionized the safety and speed of atrial fibrillation ablations. The addition of PFA technology has allowed FMC to nearly double procedural volumes and return patients to health quicker than ever before.

Atrial fibrillation can cause symptoms like heart palpitations, fatigue, and shortness of breath. Individuals with afib are five times more likely to suffer a stroke than the general population. If you or someone you know has afib, speaking with a healthcare provider about treatment options is crucial. Contact Fairfield Healthcare Professionals Cardiology at 740-689-4480 for more information on treatment options available at Fairfield Medical Center.